0001493152-22-002550.txt : 20220128 0001493152-22-002550.hdr.sgml : 20220128 20220128163025 ACCESSION NUMBER: 0001493152-22-002550 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220126 FILED AS OF DATE: 20220128 DATE AS OF CHANGE: 20220128 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Linscott Walt Addison CENTRAL INDEX KEY: 0001648585 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40652 FILM NUMBER: 22569285 MAIL ADDRESS: STREET 1: 1860 MONTREAL ROAD CITY: TUCKER STATE: GA ZIP: 30084 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Indaptus Therapeutics, Inc. CENTRAL INDEX KEY: 0001857044 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 863158720 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3 COLUMBUS CIRCLE STREET 2: 15TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10019 BUSINESS PHONE: 347-480-9760 MAIL ADDRESS: STREET 1: 3 COLUMBUS CIRCLE STREET 2: 15TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10019 FORMER COMPANY: FORMER CONFORMED NAME: Intec Parent Inc. DATE OF NAME CHANGE: 20210414 4 1 ownership.xml X0306 4 2022-01-26 0 0001857044 Indaptus Therapeutics, Inc. INDP 0001648585 Linscott Walt Addison C/O INDAPTUS THERAPEUTICS, INC. 3 COLUMBUS CIRCLE, 15TH FLOOR NEW YORK NY 10019 0 1 0 0 Chief Business Officer Stock Option (right to buy) 4.90 2022-01-26 4 A 0 45850 0 A 2032-01-26 Common Stock 45850 45850 D The stock option vests and becomes exercisable as to one-third of the total shares on January 26, 2023 and thereafter the remaining shares vest and become exercisable in equal quarterly installments over the following 24 months. /s/ Walt Linscott 2022-01-28